Skip to main content
MSR India Limited logo

MSR India Limited — Investor Relations & Filings

Ticker · 508922 ISIN · INE331L01026 LEI · 9845003D4C9A2EO6E749 BSE.NS Manufacturing
Open in API
Filings indexed 235 across all filing types
Latest filing 2022-12-31 Regulatory Filings
Country IN India
Listing BSE.NS 508922

About MSR India Limited

http://msrindia.in/

MSR India Limited specializes in the manufacturing and distribution of diverse product lines, primarily focusing on copper-based consumer goods and industrial components. The company is widely recognized for its Dr. Copper brand, which features seamless copper water bottles designed to leverage the antimicrobial properties of copper for health benefits. Beyond consumer products, the firm operates in the precision engineering sector, producing extruded copper products and specialized components for various industrial applications. Its manufacturing capabilities include advanced extrusion and fabrication processes. The company emphasizes innovation in product design and material science to cater to both domestic and international markets. Its portfolio also extends into the fast-moving consumer goods sector, where it develops and markets a range of household and personal care items.

Recent filings

Filing Released Lang Actions
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI ....
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It informs about the trading restrictions around the announcement of quarterly financial results but does not contain any financial data or results itself. The document is short (1803 characters) and serves as an announcement related to regulatory compliance and trading restrictions, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements.
2022-12-31 English
ln compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 201 B, we hereby submit the Related Party Transactions on consolidated ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half year ended September 30, 2021, submitted to the stock exchange (BSE Limited) in compliance with SEBI regulations. It contains detailed tabular data on related party transactions, including values and approvals by the audit committee. The document is dated November 17, 2022, and signed by a Whole-Time Director. The content is a regulatory compliance disclosure rather than a full financial report or an announcement of a report. It does not contain comprehensive financial statements or management discussion but focuses on related party transactions disclosures as required by listing obligations. This type of document fits best under Regulatory Filings (RNS) as it is a compliance disclosure filing to the exchange and does not qualify as an Annual Report, Interim Report, or Audit Report. The document length is 4318 characters, which is relatively short but contains substantive disclosure data, not just an announcement or certification.
2022-11-17 English
With reference to the subject cited, this is to inform the Exchange that at the Board meeting of M/s. MSR India Limited held on Monday, the 31st day of October, 2022 at 04.00 p.m. at the ....
Regulatory Filings
2022-10-31 English
MSR INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2022 ,inter alia, to consider and approve 1. Un-audited financial results ....
Regulatory Filings
2022-10-25 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It informs about the trading restrictions around the announcement of unaudited financial results for the quarter ended 30th September 2022. The document does not contain any financial data or results itself, nor does it announce or attach any report. It is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement, not a report.
2022-09-30 English
Subject: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Registered Office of the Company.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange's listing department, disclosing a change in the company's registered office address. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about material events or information. The content is an announcement of a change in registered office, not a financial report, management change, or other detailed filing. It is a regulatory announcement about a corporate event. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements that do not fit other specific categories. The document length is short (1711 characters), and it is not a report or certification but a disclosure letter.
2022-09-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.